Decreased interleukin-10 secretion by peripheral blood mononuclear cells in children with irritable bowel syndrome

Journal of Pediatric Gastroenterology and Nutrition

Volumn 52, Issue 4, 2011, Pages 376-381

  Hua, Man Chin ^a   Lai, Ming Wei ^a   Kuo, Ming Ling ^b   Yao, Tsung Chieh ^a   Huang, Jing Long ^a   Chen, Shu Mei ^b  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

children; interleukin 10; irritable bowel syndrome; peripheral blood mononuclear cells

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CLINICAL ARTICLE; CONSTIPATION; CYTOKINE RELEASE; DIARRHEA; DISEASE DURATION; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; FEMALE; HUMAN; IMMUNOMODULATION; IRRITABLE COLON; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; QUESTIONNAIRE;

ADOLESCENT; CELLS, CULTURED; CHILD; ESCHERICHIA COLI; FEMALE; HUMANS; IMMUNE SYSTEM DISEASES; INTERLEUKIN-10; INTERLEUKIN-6; IRRITABLE BOWEL SYNDROME; LEUKOCYTES, MONONUCLEAR; LIPOPOLYSACCHARIDES; MALE; OSMOLAR CONCENTRATION; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX; TUMOR NECROSIS FACTOR-ALPHA;

ESCHERICHIA COLI;

EID: 79953808537     PISSN: 02772116     EISSN: None     Source Type: Journal    
DOI: 10.1097/MPG.0b013e3181fd9816     Document Type: Article

References (36)

1. Liebregts T, Adam B, Bredack C, et al. Immune activation in patients with irritable bowel syndrome. Gastroenterology 2007;132:913-20. (Pubitemid 46440872)
2. Castilloux J, Noble A, Faure C. Is visceral hypersensitivity correlated with symptom severity in children with functional gastrointestinal disorders? J Pediatr Gastroenterol Nutr 2008;46:272-8.
3. Hahn BA, Yan S, Strassels S. Impact of irritable bowel syndrome on quality of life and resource use in the United States and United Kingdom. Digestion 1999;60:77-81. (Pubitemid 29042096)
4. Wyllie R. Recurrent abdominal pain of childhood. In: Kliegman RM, Behrman RE, Jenson HB, Stanton BMD, eds. Nelson Textbook of Pediatrics, 18th ed. Philadelphia: Saunders Elsevier; 2007: 1627.
5. Dinan TG, Clarke G, Quigley EM, et al. Enhanced cholinergic-mediated increase in the pro-inflammatory cytokine IL-6 in irritable bowel syndrome: role of muscarinic receptors. Am J Gastroenterol 2008;103:2570-6.
6. Longstreth GF, Thompson WG, Chey WD, et al. Functional bowel disorders. Gastroenterology 2006;130:1480-91.
7. Drossman DA, Camilleri M, Mayer EA, et al. AGA technical review on irritable bowel syndrome. Gastroenterology 2002;123:2108-31. (Pubitemid 35408332)
8. Gonsalkorale WM, Perrey C, Pravica V, et al. Interleukin 10 genotypes in irritable bowel syndrome: evidence for an inflammatory component? Gut 2003;52:91-3.
9. Spiller R, Garsed K. Postinfectious irritable bowel syndrome. Gastroenterology 2009;136:1979-88.
10. Grover M, Herfarth H, Drossman DA. The functional-organic dichotomy: postinfectious irritable bowel syndrome and inflammatory bowel disease-irritable bowel syndrome. Clin Gastroenterol Hepatol 2009; 7:48-53.
11. Parry SD, Stansfield R, Jelley D, et al. Does bacterial gastroenteritis predispose people to functional gastrointestinal disorders? A prospective, community-based, case-control study. Am J Gastroenterol 2003;98:1970-5. (Pubitemid 37185791)
12. Ohman L, Isaksson S, Lindmark AC, et al. T-cell activation in patients with irritable bowel syndrome. Am J Gastroenterol 2009;104:1205-12.
13. Chadwick VS, Chen W, Shu D, et al. Activation of the mucosal immune systemin irritable bowel syndrome. Gastroenterology 2002;122:1778-83. (Pubitemid 34651421)
14. Törnblom H, Lindberg G, Nyberg B, et al. Full-thickness biopsy of the jejunum reveals inflammation and enteric neuropathy in irritable bowel syndrome. Gastroenterology 2002;123:1972-9. (Pubitemid 35408321)
15. Cremon C, Gargano L, Morselli-Labate AM, et al. Mucosal immune activation in irritable bowel syndrome: gender-dependence and association with digestive symptoms. Am J Gastroenterol 2009;104:392-400.
16. Collins SM. Dysregulation of peripheral cytokine production in irritable bowel syndrome. Am J Gastroenterol 2005;100:2517-8.
17. O'Mahony L, McCarthy J, Kelly P, et al. Lactobacillus and bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles. Gastroenterology 2005;128:541-51. (Pubitemid 40585355)
18. van der Veek PP, van den Berg M, de Kroon YE, et al. Role of tumor necrosis factor-alpha and interleukin-10 gene polymorphisms in irritable bowel syndrome. Am J Gastroenterol 2005;100:2510-6.
19. Thompson WG, Longstreth GF, Drossman DA, et al. Functional bowel disorders and functional abdominal pain. Gut 1999;45(Suppl 2):II43-7.
20. Tesler MD, Savedra MC, Holzemer WL, et al. The word-graphic rating scale as a measure of children's and adolescents' pain intensity. Res Nursing Health 1991;14:361-71.
21. Hyams JS, Burke G, Davis PM, et al. Abdominal pain and irritable bowel syndrome in adolescents: a community-based study. J Pediatr 1996;129:220-6. (Pubitemid 27483793)
22. Rey E, Talley NJ. Irritable bowel syndrome: novel views on the epidemiology and potential risk factors. Dig Liver Dis 2009;41:772-80.
23. Bouman A, Heineman MJ, Faas MM. Sex hormones and the immune response in humans. Hum Reprod Update 2005;11:411-23. (Pubitemid 40895468)
24. Youssef NN, Murphy TG, Langseder AL, et al. Quality of life for children with functional abdominal pain: a comparison study of patients' and parents' perceptions. Pediatrics 2006;117:54-9. (Pubitemid 46050519)
25. Windle HJ, Ang YS, Athie-Morales V, et al. Human peripheral and gastric lymphocyte responses to Helicobacter pylori NapA and AphC differ in infected and uninfected individuals. Gut 2005;54:25-32. (Pubitemid 40007214)
26. Karlsson H, Larsson P, Wold AE, et al. Pattern of cytokine responses to Gram-positive and Gram-negative commensal bacteria is profoundly changed when monocytes differentiate into dendritic cells. Infect Immun 2004;72:2671-8. (Pubitemid 38542393)
27. Collins SM. The immunomodulation of enteric neuromuscular function: implications for motility and inflammatory disorders. Gastroenterology 1996;111:1683-99. (Pubitemid 26404236)
28. Turner DM, Williams DM, Sankaran D, et al. An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet 1997;24:1-8. (Pubitemid 27050850)
29. Barreau F, Ferrier L, Fioramonti J, et al. New insights in the etiology and pathophysiology of irritable bowel syndrome: contribution of neonatal stress models. Pediatr Res 2007;62:240-5. (Pubitemid 47301468)
30. O'Mahony SM, Marchesi JR, Scully P, et al. Early life stress alters behavior, immunity, and microbiota in rats: implications for irritable bowel syndrome and psychiatric illnesses. Biol Psychiatry 2009;65:263-7.
31. Mayer EA, Naliboff BD, Chang L, et al. V. Stress and irritable bowel syndrome. Am J Physiol Gastrointest Liver Physiol 2001;280:G519-24.
32. Brydon L, Edwards S, Jia H, et al. Psychological stress activates interleukin-1beta gene expression in human mononuclear cells. Brain Behav Immun 2005;19:540-6. (Pubitemid 41407703)
33. Maes M, Song C, Lin A, et al. The effects of psychological stress on humans: increased production of pro-inflammatory cytokines and a Th1-like response in stress-induced anxiety. Cytokine 1998;10:313-8. (Pubitemid 28227076)
34. Shulman RJ, Eakin MN, Czyzewski DI, et al. Increased gastrointestinal permeability and gut inflammation in children with functional abdominal pain and irritable bowel syndrome. J Pediatr 2008;153:646-50.
35. Nakamura M, Saito H, Kasanuki J, et al. Cytokine production in patients with inflammatory bowel disease. Gut 1992;33:933-7.
36. Gross V, Andus T, Caesar I, et al. Evidence for continuous stimulation of interleukin-6 production in Crohn's disease. Gastroenterology 1992;102:514-9.